Privia Health Group Inc
PRVA
Get informed when a big investor buys or sells
+ FollowCurrent Fair Value
118.6% upsideUndervalued by 118.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.71 Billion |
|---|---|
| Enterprise Value | $-407,792,481,880.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.19 |
| Beta | 0.97 |
| Outstanding Shares | 124,153,000 |
Return
| Return on Equity | 1.62% |
|---|---|
| Return on Assets | 0.86% |
| Return on Invested Capital | 0.01% |
Valuation & Multiples
| P/E Ratio | 122.71 |
|---|---|
| PEG | 0.17 |
| Price to Sales | 1.15 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -181.52 |
| Enterprise Value to EBIT | -9824.67 |
| Enterprise Value to Net Income | -34 |
| Total Debt to Enterprise | -0.02 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 114,100▲ 379.41% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 98.13%▼ 0.24% |
|---|---|
| Total Invested | $2.49B▼ 13.15% |
| Investors Holding | 295▲ 19.00% |
ESG Score
No data
About Privia Health Group Inc
559 employeesPrivia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for del...
Relevant Senate Committees
Controls Medicare and Medicaid policy; its decisions on value-based care reimbursement and physician payments are central to Privia's revenue model.
Determines the actual cash flow and funding levels for CMS and HHS, which directly affects the healthcare reimbursement rates Privia relies on.
Primary regulator of the healthcare industry and the FDA; directly influences the clinical and labor environment in which Privia operates.